Sanofi's (SNY.US) BTK inhibitor approved for market launch in ChinaZhitong Finance · 3 Sep 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)TipRanks · 17 Sep 2026
Sanofi (SNY.US) has submitted a new indication for its long-acting RSV monoclonal antibody for marketing approval.Zhitong Finance · 7 Aug 2026
TD Cowen Maintains Sanofi(SNY.US) With Hold Rating, Maintains Target Price $57Market news · 31 Aug 2026
Sanofi (SNYNF) Gets a Hold From J.P. MorganTipRanks · 31 Jul 2026
6-K: Sanofi Achieves Double - Digit Sales Growth in the Second Quarter, With a Steady Increase in Business Earnings per Share. 2025 Sales Guidance Is Now High Single-Digit Growth, At Upper End of RangeSEC · 31 Jul 2026
Despite raising its earnings guidance in the new CEO's debut, Sanofi (SNY.US) saw its share price fall, as a pipeline drought of new drugs emerges as a critical vulnerability.Zhitong Finance · 30 Jul 2026
6-K: Sanofi to Acquire Vigil Neuroscience, Inc., Adding a New Investigational Medicine to Treat Alzheimer's Disease to the Neurology PipelineSEC · 22 May 2026
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.2%)SEC · 7 Feb 2026
Novavax | 8-K: Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone PaymentSEC · 4 Nov 2026
Sanofi | 6-K: Sanofi to Acquire Inhibrx, Inc., Adding Potential Best-in-Class Rare Disease Asset for Alpha-1 Antitrypsin Deficiency to PipelineSEC · 23 Jan 2026